Clinical Trials
20 trialsNCT03673332 2026-01-22
EPITOP-01
Institut Paoli-Calmettes
Phase 4 Terminated
NCT05834569 2025-09-05
Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients
Korea University Guro Hospital
Phase 4 Terminated
NCT03672643 2024-11-08
Long Term Safety Observation of Crizotinib in Chinese NSCLC Population
Pfizer
Phase 4 Terminated
NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
NCT04792970 2023-09-28
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
Duke University
Phase 4 Terminated
NCT04381494 2023-06-22
ON TRAX
AstraZeneca
Phase 4 Terminated
NCT04155008 2022-11-16
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Montefiore Medical Center
Phase 4 Terminated
NCT03655821 2022-05-13
IMPROVE-II
Radboud University Medical Center
Phase 4 Terminated
NCT03200600 2021-07-13
Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery
Peking University First Hospital
Phase 4 Terminated
NCT03642457 2020-09-30
Efficacy Between Serratus Plane Block And Local Infiltration In Vats
Icahn School of Medicine at Mount Sinai
Phase 4 Terminated
NCT03460678 2020-03-05
Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.
Hikma Pharmaceuticals LLC
Phase 4 Terminated
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT03172988 2019-03-05
Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery
Peking University First Hospital
Phase 4 Terminated
NCT00075179 2018-11-07
Natrecor in Pulmonary Hypertension
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated
NCT02695290 2017-09-18
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
Boehringer Ingelheim
Phase 4 Terminated
NCT00492843 2016-02-17
Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
Chinese Society of Lung Cancer
Phase 4 Terminated
NCT01064050 2015-07-28
SPOC
Centre Hospitalier Universitaire de Saint Etienne
Phase 4 Terminated
NCT00747916 2015-07-16
Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")
CSA Medical, Inc.
Phase 4 Terminated
NCT00536107 2013-10-01
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca
Phase 4 Terminated